Why the study?
ABI is conventionally calculated using systolic blood pressure, but no study had evaluated ABI calculated using mean arterial pressure or diastolic blood pressure for predicting mortality in AMI patients.
Does ankle-brachial index calculated using diastolic blood pressure improve prediction of mortality in patients with acute myocardial infarction?
Does ankle-brachial index calculated using diastolic blood pressure improve prediction of mortality in patients with acute myocardial infarction?
Calculating the ankle-brachial index using diastolic blood pressure (cutoff < 0.78) provides superior predictive value for cardiovascular and all-cause mortality in AMI patients compared to traditional systolic ABI.
ABImap and ABIdbp may aid mortality prediction in AMI; leaves open validation against ABIsbp in larger prospective cohorts.
A low ankle-brachial index (ABI) calculated using systolic blood pressure (SBP) (ABIsbp) is associated with poor cardiovascular outcome in patients with acute myocardial infarction (AMI). ABI is always calculated using SBP clinically. However, there was no study investigating ABI calculated using mean artery pressure (MAP)(ABImap) and diastolic blood pressure (DBP)(ABIdbp) for mortality prediction in AMI patients. Therefore, our study was aimed to investigate the issue. 199 AMI patients were enrolled. Different ABIs were measured by an ABI-form device. The median follow-up to mortality was 64 months. There were 40 cardiovascular and 137 all-cause mortality. The best cutoff values of ABImbp and ABIdbp for mortality prediction were 0.91 and 0.78, respectively. After multivariate analysis, only ABIdbp and ABIdbp < 0.78 could predict cardiovascular mortality (P ≤ .047). However, all of six ABI parameters, including ABIsbp, ABImap, ABIdbp, ABIsbp < 0.90, ABImap < 0.91, and ABIdbp < 0.78, could predict all-cause mortality (P ≤ .048). In a direct comparison of six ABI models for prediction of all-cause mortality, basic model + ABIdbp <0.78 had the highest predictive value (P ≤ .025). In conclusion, only ABIdbp and ABIdbp < 0.78 could predict cardiovascular and all-cause mortality after multivariate analysis in our study. Furthermore, when adding into a basic model, ABIdbp < 0.78 had the highest additively predictive value for all-cause mortality in the six ABI parameters. Hence, calculation of ABI using DBP except SBP might provide an extra benefit in prediction of cardiovascular and all-cause mortality in AMI patients.
No takes yet. Share an insight, caveat, or question.
Hsu et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: